Kidney Transplant; ComplicationsDigital healthDevice
What this study is
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
What's being tested
- Dexcom G6
Intervention · DEVICE
access to continuous glucose monitoring in the Dexcom G6 arm 24/7
- Dexcom G6 blinded sensor
Intervention · DEVICE
retrospective access to continuous glucose profile after 10 days of wear
Study details
- Official title
- Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients
- Sponsor
- University of California, Davis
- Conditions
- Kidney Transplant; Complications · Diabetes Mellitus, Type 2 · Insulin Dependent Diabetes
- Enrolling
- 80 people
- Starts
- 2021-06-29
- Est. completion
- 2026-12-31
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age 18 or above
- Received a kidney transplant within the past year with functioning kidney (eGFR > 30 mL/min
- Person with Type 2 Diabetes and on insulin
- Access to home wi-fi connection
You can't join if
- Person with Type 1 Diabetes
- Patients taking hydroxyurea
- Patient unable to wear the Dexcom G6 device at all times for any reason
- Must be able to test blood glucose with meter 4x a day when on blinded CGM.
- Presence of clinically significant visual or cognitive impairment
- Illiterate
- Prisoners
- Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
- Presence of clinically unstable cardiovascular disease
- Active malignancy treatment
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUC Davis Health
Sacramento, California, United States
- Dahlia Zuidema, PharmD · Contact916-734-4009dmzuidema@ucdavis.edu
Recruiting
Study team
Sponsor
University of California, Davis
Study ID 1554226
Study director
Ling Chen, MD
UCDavis Transplant Nephrology
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.